FDA biostatistician recommends transparency, early conversation with reviewers
Regulatory NewsFerdous Al-Faruque
Diagnostics/IVDsMedical DevicesRegulatory Intelligence/PolicyUnited StatesRegulatory NewsFerdous Al-FaruqueDiagnostics/IVDsMedical DevicesRegulatory Intelligence/PolicyUnited States